Home > Products > CEA & TNFα
> Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scIgG)
Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scIgG) (CAT#: SCIGG-142)
Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CEA and anti-TNFα IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget cytokine (TNFα) to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scIgG) (SCIGG-142). Click the button below to contact us or submit your feedback about this product.